Recurrent Rectal Cancer Completed Phase 3 Trials for Fluorouracil (DB00544)

Also known as: Rectal cancer recurrent / Carcinoma rectum recurrent / Rectal carcinoma recurrent / Carcinoma of rectum recurrent

IndicationStatusPhase
DBCOND0028583 (Recurrent Rectal Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003873Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal CancerTreatment
NCT00005036Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerTreatment
NCT00025337Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously TreatedTreatment